Dr. Goy is the Chair of oncology for Hackensack Meridian Health, the largest health care network (16 hospitals) in New Jersey. Dr. Goy also leads its tertiary care program John Theurer Cancer Center, the largest oncology program in NJ at Hackensack University Medical Center, and a member of Memorial Sloan Kettering - Hackensack Meridian Partnership. He is Professor and Founding Chair of the Department of Oncology, at Hackensack Meridian School of Medicine at Seton Hall as well as Professor of Medicine at Georgetown University in DC.
Dr. Goy is widely-known for his work in lymphoma, particularly in drug development in mantle cell lymphoma and other aggressive lymphomas. His research interest also includes the identification of prognostic markers and better ways to stratify patients with lymphoma. Dr Goy has been on the steering committee for the NCI for lymphoma and on the scientific advisory board of the Lymphoma Research Foundation. Together with his team and the Stem Cell and Bone Marrow Transplantation Division at John Theurer Cancer Center, they have performed over 2000 bone marrow transplantation's for lymphoma patients and are exploring new forms of immunotherapy/cell therapy post transplantation particularly using checkpoint inhibitors, taking advantage of the favorable milieu during immune reconstitution post stem cell transplantation. Dr Goy has been involved in the development of CAR-T cells at Hackensack University Medical Center with the NCI for almost a decade, which led to the first approval
of CAR-T cells in lymphoma, in November 2017.
Dr. Goy believes that a true revolution is happening in cancer medicine, which will be driven by cell-based therapies/immunotherapy, precision medicine, connectivity and analytics. The bioinformatics platform developed at JTCC – called COTA – uses a unique classification system compressing all relevant individual patient data into a usable code (CNA). This digital architecture allows to reduce variance, optimize decisions in cancer care, and improve outcome at the individual level, while lowering costs for the population along the way and supporting value-based care initiatives.
Dr. Goy has published over 170 peer reviewed papers and serves as reviewer for many journals in the field including the New England Journal of Medicine, the Journal of Clinical Oncology, and Blood, the American Society of Hematology Journal, among others. He has been the co-chair of the Global Council on the Future of Health and Healthcare for the World Economic Forum since 2015. He believes that we are at an inflection point in medicine due to the unprecedented combination of exponential acceleration in science and discovery, but also technology which will help reshape both health and healthcare delivery.
Dr. Goy received his medical degree from University Joseph Fourier in Grenoble, France before completing his training in hematology oncology in Paris at the Faculté of Medicine Cochin Port Royal. While there, he also received a Master’s in Tumor Immunology from Pasteur Institute and Curie University Paris VI as well as a Master’s degree in Experimental Oncology from University Kremlin Bicetre. Dr. Goy was on faculty at Memorial Sloan-Kettering and M.D. Anderson Cancer Center before joining John Theurer Cancer Center in 2005.